Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) hit a new 52-week low on Friday . The stock traded as low as $10.12 and last traded at $10.21, with a volume of 1907894 shares. The stock ...

Pediatric patients with sickle cell anemia and a history of abnormal cerebral artery velocities had reduced hospitalizations ...

Within a few days, I was shunted out of the hospital with some meds, and pamphlets and told by a cardiologist who looked and ...

Case reports published in medical literature suggest that tafenoquine combined with standard-of-care treatment exhibits a ...

Initiate pivotal studies for NX-5948: Nurix is evaluating NX-5948 in an ongoing Phase 1b clinical trial in adults with relapsed or refractory B-cell malignancies and expects to initiate a suite of ...

Initiate a suite of clinical trials in 2025 intended to support global registration of NX-5948 for the treatment of chronic lymphocytic ...

The diagnosis of hemolytic anemia was established mainly by the clinical observation of either a fall in circulating hemoglobin levels or a loss of transfused blood in excess of 1 per cent per day.

JNJ's filing seeks the FDA's approval for nipocalimab to treat generalized myasthenia gravis in a broad population of ...

KARACHI: Elephant Sonia housed at the Safari Park suffered from multiple chronic illnesses, affecting almost all vital organs ...

Johnson & Johnson has won Food and Drug Administration priority review for its application seeking approval of nipocalimab in certain patients with generalized myasthenia gravis.

Agios Pharma submitted a sNDA to the FDA after two Phase III trials studying PYRUKYND (mitapivat) in thalassemia met their ...